JPRN-UMIN000037395已完成未知
Prospective Cohort Study of Endocrine Therapy with Abemaciclib for Chemotherapy-Treated Metastatic Breast Cancer - Abemaciclib cohort study
CSPOR-BC0 个研究点目标入组 180 人开始时间: 2019年11月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 180
研究概览
简要总结
nder analyzing
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •Exclusion Criteria 1)Women for whom endocrine therapy is not indicated. 2)Women who require oxygen inhalation because of dyspnea under resting conditions. 3)Women who have previous history of gastrectomy or small bowel resection, except for mucosal resection. 4)Women who have Crohns disease, ulcerative colitis, or chronic diarrhea of Grade 2 or higher. 5)Women who are pregnant or nursing. 6)Women undergoing treatment for bacterial or fungal infection. 7)Women who have active hepatitis B or C. 8)Women who have serious cardiac disease. 9)Women whose primary care physicians considered that they are unsuitable for inclusion in this study.
研究者
相似试验
已完成
不适用
Evaluation of Endocrine Therapy Effects of Host Immunity in Early Stage Breast CancerEstrogen Receptor-positive Breast CancerHealthyBreast CancerNCT03719495Duke University68
Unknown
不适用
Prospective Observational Study of Antitumor Activity Correlation Between Hormonal Therapy and Expression miRNA100Breast CancerNCT02950207Fondazione del Piemonte per l'Oncologia180
Unknown
不适用
Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the BreastBreast CancerNCT04666805First Hospital of China Medical University1,354
已完成
2 期
Preoperative Window of Endocrine Therapy Provides Information to Increase ComplianceNewly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast CancerNCT01614210University of Utah52
终止
不适用
EndoPredict® Extended Endocrine Trial (EXET)Primary Invasive Breast CancerNCT04016935Myriad Genetic Laboratories, Inc.855